BlueStone Venture Partners, LLC

BlueStone Venture Partners, LLC

  • Home
  • Our Firm
    • Investment Criteria
    • Team
    • Advisors
  • Portfolio
  • News
  • Contact Us

BlueStone News


  • Pyx Health to Accelerate Growth with Strategic Investment from TT Capital Partners

    July 22, 2023

    —

    in Portfolio News

  • GT Med Tech Recognized as Innovator of the Year at Governor’s Celebration of Innovation Award Ceremony

    October 14, 2021

    —

    in Portfolio News

  • Akadeum Life Sciences, Inc. Raises $17.5M Financing Round Led by Arboretum Ventures

    October 12, 2021

    —

    in New Portfolio Company

  • GT Medical Technologies Presents Clinical Data on GammaTile® Therapy for Brain Tumors at the 2021 American Association of Neurological Surgeons Scientific Virtual Meeting

    August 24, 2021

    —

    in Portfolio News

  • Boston-based tech company raises $8M to develop AI-powered CVD software

    May 13, 2021

    —

    in New Portfolio Company

  • Pyx Health Receives Strategic Investment from Rallyday Partners. BlueStone Participates in Round as Company Sees 2,000% Growth and Doubles Users of Solution to Combat Loneliness Epidemic

    April 30, 2021

    —

    in Portfolio News

  • Banner University Health Plans Reduces Hospital & Emergency Department Utilization Using Pyx Health’s Platform to Address Loneliness

    March 15, 2021

    —

    in Portfolio News

  • 2020 list of Gamma Tile Publications and Abstracts

    January 22, 2021

    —

    in Portfolio News

  • Tempe brain tumor therapy company garners $16M in capital raise

    November 23, 2020

    —

    in Portfolio News

  • GT Medical Technologies Announces Data Demonstrating Positive Local Control and Safety Outcomes with GammaTile Therapy for Large Brain Metastases

    August 18, 2020

    —

    in Portfolio News

  • The Rockefeller Foundation Launches New Testing Strategy to Keep U.S. Economy Open

    July 16, 2020

    —

    in COVID-19 News

  • GT Medical Technologies, Inc.  20 Medical Device Startups You Need to Know 

    June 26, 2020

    —

    in Portfolio News

  • HEALTH CATALYSTS: 2019 DIAGNOSTICS YEAR IN REVIEW

    April 22, 2020

    —

    in Uncategorized

  • Bioscience Startups Find Success in Tucson: Region Draws More Drug, Device and Therapeutic Companies

    March 30, 2020

    —

    in BlueStone News

  • GT Medical Technologies, Inc. named to FierceMedTech’s 2019 Fierce 15 List

    March 9, 2020

    —

    in Portfolio News

  • BlueStone Portfolio Company, Paradigm Diagnostics, Inc. Acquired by Exact Sciences Corporation

    March 6, 2020

    —

    in Portfolio News

  • GT Medical Technologies Announces FDA Clearance of Expanded Indication for GammaTile Therapy

    January 27, 2020

    —

    in Portfolio News

  • BlueStone Managing Director Mara Aspinall named to 2019 Most Influential Corporate Directors List by WomenInc. Magazine

    December 11, 2019

    —

    in BlueStone News

  • GT Medical Technologies, Inc. to be honored with an AZBio Fast Lane Award

    August 26, 2019

    —

    in Portfolio News

  • GT Medical Technologies Announces Completion of First Case in Arizona to Use GammaTile Therapy

    August 15, 2019

    —

    in Portfolio News

  • GT Medical Technologies Announces Presentation of Data Demonstrating the Safety Profile of GammaTile Therapy for Various Brain Tumors​

    June 17, 2019

    —

    in Portfolio News

  • PBS, Arizona Horizon –  Implantable Brain Tumor Treatment

    June 11, 2019

    —

    in Portfolio News

  • BLUESTONE DIRECTOR, ANDREW MORE, RECOGNIZED AS A 2019 EMERGING LEADER BY THE M&A ADVISOR

    May 31, 2019

    —

    in BlueStone News

  • Paradigm Diagnostics Announces the Addition of Industry Executive Mara Aspinall to the Board of Directors as Part of the Series B Extension Closing Totaling $15 Million

    May 14, 2019

    —

    in New Portfolio Company

  • The Creative City Show – Venture Capital and the Innovation Ecosystem in Tucson

    May 9, 2019

    —

    in BlueStone News

  • UCSF Rosenman Institute – Preventing Brain Cancer Recurrence with GammaTiles

    May 7, 2019

    —

    in Portfolio News

  • GT Medical Technologies Co-Founder to Receive Prestigious Rosenblum-Mahaley Clinical Research Award at 2019 American Association of Neurological Surgeons Annual Scientific Meeting

    April 11, 2019

    —

    in Portfolio News

  • University of Minnesota First in U.S. to Offer New Targeted Therapy for Recurrent Brain Tumors

    February 14, 2019

    —

    in Portfolio News

  • Doctors at the University of Minnesota are the first in the country to use a breakthrough brain cancer treatment

    February 14, 2019

    —

    in Portfolio News

  • GT Medical Technologies Announces $10 Million Financing to Support Launch of Targeted Therapy for Patients with Recurrent Brain Tumors

    January 31, 2019

    —

    in New Portfolio Company

  • BlueStone Venture Partners, A Local Venture Capital Fund

    December 17, 2018

    —

    in BlueStone News

  • BroadSpot Imaging Corporation Expands Series A Investment

    October 9, 2018

    —

    in New Portfolio Company

  • USNews & World Report: State Funding to Spur Development of Bioscience Startups

    August 17, 2018

    —

    in BlueStone News

  • Governor Susana Martinez Announces New Catalyst Fund Commitment to BlueStone Venture Partners

    August 16, 2018

    —

    in BlueStone News

  • BlueStone Venture Partners Announces Initial Funding Close and State of New Mexico Investment in Its Inaugural Venture Fund

    July 27, 2018

    —

    in Uncategorized

BlueStone Venture Partners, LLC

Copyright © 2025 BlueStone Venture Partners